Long-term treatment combining continuous subcutaneous insulin infusion with oral hypoglycaemic agents is effective in type 2 diabetes

Diabetes and Metabolism

Volumn 33, Issue 4, 2007, Pages 253-260

  Labrousse Lhermine, F ^a,b   Cazals, L ^a   Ruidavets, J B ^c   Hanaire, H ^a,b  

^a CHU RANGUEIL   (France)

^b The Study Group for the Development of Pump Therapy in Diabetes   (France)

^c INSERM   (France)

Author keywords

Antidiabetic oral agents; Continuous subcutaneous insulin infusion; Glycaemic control; Quality of life; Type 2 diabetes

Indexed keywords

GLIBENCLAMIDE; GLICLAZIDE; GLIPIZIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; NEUTRAL INSULIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN INFUSION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SATISFACTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE DRUG DOSE; WEIGHT GAIN;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN INFUSION SYSTEMS; MALE; METFORMIN; MIDDLE AGED; TREATMENT OUTCOME;

EID: 34548668214     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2007.01.007     Document Type: Article

References (26)

1. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
2. Hanaire-Broutin H., Melki V., Bessières-Lacombe S., Tauber J.P., and The Study Group for the Development of Pump Therapy in Diabetes. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. Diabetes Care 23 (2000) 1232-1235
3. DeVries J.H., Snoek F.J., Kostense P.J., Masurel N., and Heine R.J. Dutch Insulin Pump Study Group: a randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycaemic control. Diabetes Care 25 (2002) 2074-2080
4. Pickup J., Mattock M., and Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. BMJ 324 (2002) 705-711
5. Pickup J., and Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 25 (2002) 593-598
6. Retnakaran R., Hochman J., DeVries J.H., Hanaire-Broutin H., Heine R.J., Melki V., et al. Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c. Diabetes Care 27 (2004) 2590-2596
7. Raskin P., Bode B.W., Marks J.B., Hirsch I.B., Weinstein R.L., McGill J.B., et al. Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes. Diabetes Care 26 (2003) 2598-2603
8. Herman W.H., Ilag L.L., Johnson S.L., Martin C.L., Sinding J., Al Harthi A., et al. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care 28 (2005) 1568-1573
9. Wainstein J., Metzeger M., Boaz M., Minuchin O., Cohen Y., Yaffe A., et al. Insulin pump therapy vs. multiple daily injections in obese type 2 diabetic patients. Diab Med 22 (2005) 1037-1046
10. Fagot-Campagna A., Simon D., Varroud-Vial M., Ihaddadène K., Vallier N., Scaturro S., et al. Caractéristiques des personnes diabétiques traitées et adéquation du suivi médical du diabète aux recommandations officielles. Entred 2001. Bull. Epidemiol. Hebdo. INVS 49-50 (2003) 238-239
11. Shorr R.I., Franse L., Resnick H.E., Di Barri M., Johnson K.C., and Pahor M. Glycaemic control of older adults with type 2 diabetes: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. J. Am. Geriatr. Soc. 48 (2000) 264-267
12. Tsui E., Barnie A., Ross S., Parkes R., and Zinman B. Intensive insulin therapy with insulin lispro: a randomized trial of continuous subcutaneous insulin infusion versus multiple daily insulin injection. Diabetes Care 241 (2001) 722-727
13. Jennings A.M., Lewis K.S., Murdoch S., Talbot J.F., Bradley C., and Ward J.D. Randomized trial comparing continuous subcutaneous insulin infusion and conventional insulin therapy in type II diabetic patients poorly controlled with sulfonylureas. Diabetes Care 14 (1991) 738-744
14. Glaser B., Leibovich G., Nesher R., Hartling S., Binder C., and Cerasi E. Improved beta-cell function after intensive insulin treatment in severe non-insulin dependent diabetes. Acta Endocrinol. (Copenh.) 118 (1988) 365-373
15. Wainstein J., Metzger M., Menuchin O., Cohen Y., Raz I., and for the Israeli Diabetes Research Group. Insulin pump therapy versus multiple daily injections in obese type 2 diabetic patients. Diabetologia 44 (2001) A26 (Abstract)
16. Type 2 diabetes treatment. French recommendations for good practice. Afssaps-HAS. Diabetes Metab. 32 (2006) 643-648
17. ADA position statement: standards of medicinal care in diabetes. Diabetes Care 27 (2004) 515-535
18. Stratton I.M., Adler A.I., Neil H.A., Matthews D.R., Manley S.E., Cull C.A., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321 (2000) 405-412
19. UKPDS Study Group. UKPDS 16. Overview of six years' therapy of type II diabetes: a progressive disease. Diabetes 44 (1995) 1249-1258
20. Yki-Jarvinen H. Combination therapies with insulin in type 2 diabetes. Diabetes Care 24 (2001) 758-767
21. Makimattila S., Nikkilä K., and Yki-Jarvinen H. Causes of weight gain during insulin therapy with and without metformin in patients with type 2 diabetes mellitus. Diabetologia 42 (1999) 406-412
22. Yki-Jarvinen H., Ryysy L., Nikkilä K., Tulokas T., Vanamo R., and Heikkila M. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus: a randomized controlled trial. Ann. Intern. Med. 130 (1999) 389-396
23. Ohkubo Y., Kishikawa H., Araki E., Miyata T., Isami S., Motoyoshi S., et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent mellitus a randomized prospective 6-year study. Diabetes Res. Clin. Pract. 28 (1995) 103-117
24. Abraira C., Colwell J., Nuttall F., Sawin C.T., Henderson W., Comstock J.P., et al. Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on glycaemic control and complications in type II diabetes. Arch. Intern. Med. 157 (1997) 181-188
25. Testa M.A., Hayes J.F., Turner R.R., and Simonson D.C. Patient acceptance and satisfaction with intensive insulin therapy in type 2 diabetes: a randomized trial of the insulin pen versus pump. Diabetes 50 Suppl. 2 (2001) A428 (Abstract)
26. Turner R.R., Testa M.A., Hayes J.F., and Simonson D.C. Patient satisfaction with intensive insulin therapy in type 2 diabetes: a randomized trial of the insulin pen versus pump. Diabetologia 44 (2001) A26 (Abstract)